{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:40:01Z","timestamp":1792683601102,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.toxlet.2026.113202","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:50:54Z","timestamp":1789602654000},"page":"113202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional perturbation reveals context-dependent contributions of nuclear receptors to drug-induced hepatic steatosis"],"prefix":"10.1016","volume":"425","author":[{"given":"Kaidi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twan","family":"van den Beucken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2026.113202_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/432647","article-title":"Modes-of-action related to repeated dose toxicity: tissue-specific biological roles of PPAR \u03b3 ligand-dependent dysregulation in nonalcoholic fatty liver disease","volume":"2014","author":"Al Sharif","year":"2014","journal-title":"PPAR Res."},{"key":"10.1016\/j.toxlet.2026.113202_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114650","article-title":"Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations","volume":"217","author":"Bajard","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.toxlet.2026.113202_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153767","article-title":"Gene expression profiling reveals that PXR activation inhibits hepatic PPAR\u03b1 activity and decreases FGF21 secretion in male C57Bl6\/J mice","volume":"20","author":"Barretto","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2026.113202_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2026.113202_bib5","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113202_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.toxlet.2026.113202_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/pr.112.006833","article-title":"Nuclear receptors and their selective pharmacologic modulators","volume":"65","author":"Burris","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxlet.2026.113202_bib8","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2026.113202_bib9","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3390\/ijms27093825","article-title":"Discrimination of Steatotic and Non-Steatotic Chemicals Through Transcriptome Analysis in Primary Human Hepatocytes","volume":"27","author":"Cramer Von Clausbruch","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2026.113202_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13578-024-01317-2","article-title":"Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques","volume":"14","author":"Guo","year":"2024","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.toxlet.2026.113202_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2026.154457","article-title":"Reduced NR2F6 expression reshapes the VPA-induced transcriptome in human hepatocytes and increases lipid accumulation","volume":"524","author":"Guo","year":"2026","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2026.113202_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/460208a","article-title":"Toxicology for the twenty-first century","volume":"460","author":"Hartung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2026.113202_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/mp800131d","article-title":"Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice","volume":"6","author":"Hoekstra","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxlet.2026.113202_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/aps.2014.116","article-title":"Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis","volume":"36","author":"Jiao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.toxlet.2026.113202_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-025-02270-3","article-title":"Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions","volume":"10","author":"Jin","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.toxlet.2026.113202_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00204-019-02445-2","article-title":"Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines","volume":"93","author":"Knebel","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113202_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116676","article-title":"Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells","volume":"477","author":"Krajcova","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2026.113202_bib18","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/liv.15571","article-title":"Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions","volume":"43","author":"Li","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2026.113202_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105203","article-title":"Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways","volume":"25","author":"L\u00f3pez-Pascual","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2026.113202_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/acs.chemrestox.8b00112","article-title":"Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole","volume":"31","author":"Luckert","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113202_bib21","doi-asserted-by":"crossref","first-page":"25776","DOI":"10.1074\/jbc.M116.752311","article-title":"Glucocorticoid Receptor \u03b2 Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) \u03b1","volume":"291","author":"Marino","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2026.113202_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.122.001301","article-title":"Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease","volume":"383","author":"Patil","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2026.113202_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/168905","article-title":"Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease","volume":"2015","author":"Rabinowich","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.toxlet.2026.113202_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41580-022-00486-7","article-title":"Transcriptional control of energy metabolism by nuclear receptors","volume":"23","author":"Scholtes","year":"2022","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2026.113202_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2026.113202_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2026.112153","article-title":"A combined in silico and in vitro new approach methodology for early detection of liver steatogenic chemicals","volume":"435","author":"Verhoeven","year":"2026","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2026.113202_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.toxlet.2026.113202_bib28","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1073\/pnas.0438010100","article-title":"Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor","volume":"100","author":"Xie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.toxlet.2026.113202_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426024318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426024318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:51:17Z","timestamp":1792680677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427426024318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S0378427426024318"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.113202","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional perturbation reveals context-dependent contributions of nuclear receptors to drug-induced hepatic steatosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.113202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113202"}}